Company Profile
Updated: 05-NOV-09Advanced Renal Technologies
Private Company, Headquarters Location
40 Lake Bellevue Dr., Ste. 100, Bellevue, WA 98005, United States
(800)346-2080, (425)453-8777, (425)451-9438 fax, http://www.citrasate.com
Primary SIC: Biological Products Except Diagnostic, Primary NAICS: Biological Product (except Diagnostic) Manufacturing
Description: Manufacturing: Biological Products Except Diagnostic
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Yale's scan of Turkish infant's genome yields a surprise diagnosis.
NewsRx Science; 11/8/2009; 901 words; ...of emerging genetic technologies, Yale University researchers...and, as cost of the technology decreases, will be...approach is a marriage of advanced DNA sequencing technology and microarray protocols...doctor, they used technology to conduct a genetic...caused by mutations in renal ...
Other News To Note.
BIOWORLD Today; 11/4/2009; 3567 words; ...additional targets. o Advanced Magnetics Inc...cancer. o Argonaut Technologies Inc., of Foster...efforts. o Caliper Technologies Corp., of Mountain...siRNA gene-silencing technology to cultured mouse...April licensed RNAi technology from the medical school...initial platelet count, ...
Inex Presents Interim NHL Trial Results With 100% Response.
BIOWORLD Today; 11/4/2009; 2524 words; ...s liposomal drug delivery technology, Transmembrane Carrier System...its two Phase III trials in renal-cell carcinoma with Neovastat...of BNP7787 in patients with advanced non-small-cell lung cancer...chemoprotecting agent. Bio-Technology General Corp., of Iselin...
QUARK PHARMA TO PRESENT DATA ON ITS SIRNA THERAPEUTIC PROGRAMS.
AsiaPulse News; 11/3/2009; 1228 words; ...delayed graft function (DGF) following renal transplantation. Both studies are scheduled...to drug development. Quark's RNAi technology includes novel siRNA structures and chemistry...developed by Quark, is being evaluated in advanced IND-enabling preclinical studies as...
Kosan's Offering Brings In $39.4M For R&D Work.
BIOWORLD Today; 11/3/2009; 969 words; ...or invest in businesses, products and technologies. Kosan focuses on cancer products and...for melanoma, lymphoma, and breast, renal and thyroid cancers, as well as Phase...an NCI-sponsored Phase I study for advanced malignancies, and a Kosan-sponsored...
Recent News Articles
- Fresenius Medical Care North America Announces Distribution and Supply Agreement with Advanced Renal Technologies, Inc.
Business Wire - July 01, 2009 - Laparoscopic cryo is effective in some cystic renal tumors: risk of rupture, tissue damage are offset by benefits in select patients, study finds.(Advances in Technology)
Urology Times - October 15, 2006 - Rockwell battles competitor over name of dialysis product; Lawsuits filed over product names Dryalysate, Dri-sate.(News)(Rockwell Medical Technologies Inc v Advanced Renal Technologies)(trademark infringement case)(Case overview)
Crain's Detroit Business - March 20, 2006
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning